StocksMedium•21 October 2026•
1 min read
Abbott Lowers 2026 Sales Growth Forecast on Medical Device Weakness
Key Facts
1Abbott lowered its 2026 sales growth forecast, citing weakness in its medical device division.
Abbott Laboratories lowered its 2026 sales growth forecast. Reuters reported that the company cited weakness in its medical device division as the primary reason for the downward revision of its full-year outlook.
ABT closed at $102.45 on October 20, 2026, after trading between a low of $100.75 and a high of $105.62 during that session. The adjustment reflects weaker-than-anticipated performance or demand within the company's medical device business unit.